财务摘要(报告期)(Applied Therapeutics Inc)
2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
---|---|---|---|---|---|---|---|---|
每股指标: | ||||||||
每股收益EPS基本(元) | -1.42 | -1.09 | -0.59 | -0.18 | -2.18 | -4.04 | -1.84 | -0.88 |
每股净资产(元) | -0.20 | -0.14 | -0.07 | -0.08 | 0.08 | 0.20 | 0.56 | 1.60 |
每股经营现金净流量(元) | -0.65 | -0.49 | -0.38 | -0.15 | -1.62 | -1.29 | -0.93 | -0.93 |
每股现金流量净额(元) | 0.39 | 0.27 | 0.31 | 0.13 | -0.77 | -0.28 | 0.04 | -0.60 |
每股营业收入(元) | 0.12 | 0.14 | 0.17 | 0.22 | - | - | - | - |
盈利能力: | ||||||||
销售毛利率(%) | 100.00 | 100.00 | 100.00 | 100.00 | - | - | - | - |
销售净利率(%) | -1,198.47 | -770.02 | -372.55 | -95.09 | - | - | - | - |
净资产收益率平均(%) | 1,830.54 | 2,350.97 | 29,094.51 | 184,309.09 | -247.77 | -377.34 | -110.88 | -44.25 |
总资产净利率(%) | -257.01 | -196.47 | -96.85 | -29.65 | -128.66 | -185.79 | -58.28 | -29.86 |
投入资本回报率ROIC(%) | -899.09 | -557.56 | -267.11 | -70.41 | -285.94 | -520.73 | -167.58 | -73.70 |
收益质量: | ||||||||
营业利润/利润总额(%) | 53.89 | 53.03 | 70.59 | 107.11 | 100.54 | 93.98 | 91.11 | 99.91 |
经营活动产生的现金流量净额/营业收入(%) | -552.12 | -358.05 | -219.91 | -65.57 | - | - | - | - |
资本结构: | ||||||||
资产负债率(%) | 131.27 | 124.44 | 109.93 | 113.57 | 89.41 | 83.01 | 66.99 | 35.39 |
权益乘数 | -3.20 | -4.09 | -10.07 | -7.37 | 9.45 | 5.89 | 3.03 | 1.55 |
产权比率 | -4.20 | -5.09 | -11.07 | -8.37 | 8.45 | 4.89 | 2.03 | 0.55 |
流动资产/总资产(%) | 99.18 | 98.44 | 98.11 | 96.86 | 97.25 | 97.94 | 98.36 | 97.86 |
非流动资产/总资产(%) | 0.82 | 1.56 | 1.89 | 3.14 | 2.75 | 2.06 | 1.64 | 2.14 |
流动负债/负债合计(%) | 98.89 | 98.69 | 98.35 | 97.58 | 97.44 | 98.86 | 98.75 | 96.64 |
非流动负债/负债合计(%) | 1.11 | 1.31 | 1.65 | 2.42 | 2.56 | 1.14 | 1.25 | 3.36 |
归属母公司股东的权益/投入资本(%) | -347.44 | -142.72 | -53.97 | -57.46 | 18.71 | 59.11 | 114.96 | 156.94 |
偿债能力: | ||||||||
流动比率 | 0.76 | 0.80 | 0.91 | 0.87 | 1.12 | 1.19 | 1.49 | 2.86 |
速动比率 | 0.76 | 0.80 | 0.91 | 0.87 | 1.12 | 1.19 | 1.49 | 2.86 |
货币资金/流动负债(%) | 70.10 | 67.49 | 75.48 | 68.92 | 49.84 | 86.83 | 107.76 | 172.00 |
营业利润/流动负债(%) | -90.66 | -78.42 | -59.41 | -32.65 | -248.17 | -275.09 | -86.28 | -103.98 |
经营活动产生的现金流量净额/流动负债(%) | -77.51 | -68.77 | -49.68 | -21.02 | -233.64 | -133.72 | -82.78 | -109.87 |
归属母公司股东的权益/负债合计(%) | -23.82 | -19.64 | -9.03 | -11.95 | 11.84 | 20.47 | 49.28 | 182.53 |
经营活动产生的现金流量净额/负债合计(%) | -76.65 | -67.87 | -48.86 | -20.51 | -227.66 | -132.20 | -81.75 | -106.18 |
营业利润/负债合计(%) | -89.66 | -77.40 | -58.43 | -31.86 | -241.82 | -271.96 | -85.21 | -100.48 |
成长能力: | ||||||||
总资产同比增长率(%) | 42.93 | -20.26 | -44.17 | -53.81 | -57.32 | -52.19 | -42.92 | -58.42 |
每股净资产同比增长率(%) | -339.11 | -171.46 | -112.50 | -105.29 | -96.46 | -93.94 | -87.03 | -69.21 |
总负债同比增长率(%) | 109.84 | 19.53 | -8.38 | 48.22 | 25.40 | 47.74 | 113.59 | 9.49 |
基本每股收益同比增长率(%) | 34.86 | 46.04 | 67.93 | 79.55 | 47.09 | 34.42 | 7.54 | 12.00 |
归属母公司股东的权益同比增长率(%) | -522.21 | -214.70 | -116.79 | -109.70 | -93.51 | -88.89 | -77.05 | -68.97 |
营业利润同比增长率(%) | 22.20 | 31.97 | 37.17 | 53.00 | 21.46 | 18.50 | 10.89 | 4.54 |
股东权益合计同比增长率(%) | -522.21 | -214.70 | -116.79 | -109.70 | -93.51 | -88.89 | -77.05 | -68.97 |
营运能力: | ||||||||
流动资产周转率次(次) | 0.22 | 0.26 | 0.27 | 0.32 | - | - | - | - |
总资产周转率次(次) | 0.21 | 0.26 | 0.26 | 0.31 | - | - | - | - |
衍生指标: | ||||||||
现金及现金等价物净增加额TTM(元) | 33,241,000.00 | -2,931,000.00 | -20,112,000.00 | -15,297,000.00 | -37,231,000.00 | -29,819,000.00 | -22,706,000.00 | -45,853,000.00 |
利润总额TTM(元) | -119,763,000.00 | -96,513,000.00 | -73,244,000.00 | -69,524,000.00 | -82,508,000.00 | -84,892,000.00 | -104,555,000.00 | -104,526,000.00 |
毛利TTM(元) | 9,993,000.00 | - | - | - | - | - | - | - |
投入资本(元) | 4,935,000.00 | 7,738,000.00 | 8,030,000.00 | 7,087,000.00 | 21,706,000.00 | 16,291,000.00 | 22,450,000.00 | 26,739,000.00 |
经营活动产生的现金流量净额TTM(元) | -55,173,000.00 | -54,061,000.00 | -58,725,000.00 | -60,673,000.00 | -78,093,000.00 | -89,142,000.00 | -85,417,000.00 | -92,925,000.00 |
总营业收入TTM(元) | 9,993,000.00 | - | - | - | - | - | - | - |
归属母公司净利润TTM(元) | -119,763,000.00 | -96,513,000.00 | -73,244,000.00 | -69,524,000.00 | -82,508,000.00 | -84,892,000.00 | -104,555,000.00 | -104,526,000.00 |